This test is not orderable.

OnkoSight Plasma Cell Myeloma NGS Panel Build info

Synonyms

  • ONKOSIGHT PLASMA CELL MYELOMA NGS PANEL
  • ONKOMM
  • MULITPLE
  • LAB4183

Short Name

ONKOSIGHT PLASMA CELL MYELOMA NGS PANEL

Procedure Master Number

LAB4183

Procedure ID

192039

Clinical Info

Clinical Utility:   50 gene panel which includes Tumor Mutation Burden (TMB) and microsatellite instability (MSI)
AKT1, AKT2, AKT3, ATM, ATR, B2M, BIRC3, BRAF, CARD11, CCND1, CDK4, CDKN1B, CDKN2A, CXCR4, CYLD, DIS3, DNMT3A, EGFR, FAM46C, FGFR3
FUBP1, IDH1, IDH2, IGF1R, IKZF1, IRF4, JAK2, KDM6A, KRAS, MAX, MYC, MYD88, NF1, NFKBIA, NOTCH1, NRAS, PIK3CA, PIK3CG, PIK3R1, PIK3R2
PIM1, PRDM1, PTPN11, RB1, STAT3, TERT, TET2, TGFBR2, TP53, TRAF2

Specimen Sources

 Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

 Blood

Container

Bone Marrow - Lavender Top

Collection Instructions

Alternative Specimen: Formalin-fixed, Paraffin-embedded Tissue, Bone Marrow DNA, Bone Marrow - Green Top, Eppendorf tube, Peripheral Blood - Green Top, Peripheral Blood - Lavender Top

Transport Instructions

Room Temperature

Specimen Stability

Methodology

MM NGS Panel

Days Performed

Performing Laboratory

BioReference Laboratory
Test Code: TL67-3

CPT

81450 X 1

PDM

 245205

Only Orderable at Locations:

 Orderable Everywhere

Results
Component Name Base Name Common Name External Name
ONKOSIGHT MYELOMA NGS PANEL - PB/BM ONKOMYELONGS ONKOSIGHT MYELOMA NGS OnkoSight Myeloma NGS Panel - PB/BM
THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS THERPROGASS THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS Therapeutic And Prognostic Associations
INTERPRETATION SUMMARY INTERP INTERPRETATION SUMMARY Interpretation Summary
DETAILED GENETIC INTERPRETATION 1 DETAILGENINT DETAILED GENETIC INTERPRETATION 1 Detailed Genetic Interpretation 1
DETAILED GENETIC INTERPRETATION 2 : DETAILGENINT DETAILED GENETIC INTERPRETATION 2 Detailed Genetic Interpretation 2 :
CLINICAL TRIALS 1 : CLINTRIAL CLINICAL TRIALS 1 Clinical Trials 1 :
CLINICAL TRIALS 2 : CLINTRIAL CLINICAL TRIALS 2 Clinical Trials 2 :
TECHNICAL SUMMARY : TECHSUM TECHNICAL SUMMARY Technical Summary :
METHODS METHODS METHODS Methods
REFERENCES 1 REF1 REFERENCES 1 References 1
REFERENCES 2 REF2 REFERENCES 2 References 2
REPORT FOOTER RPTFOOTER REPORT FOOTER Report Footer
ADDENDUM : ADDENDUM ADDENDUM
ALLELE FREQUENCIES: ALLELE ALLELE FREQUENCIES Allele Frequencies:

Forms
edit